✦ LIBER ✦

A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A piedmont oncology association study

✍ Scribed by Douglas R. White; Bayard L. Powell; Johnny B. Craig; Robert K. Stuart; Frederick M. Schnell; Gerald A. Goldklang; James N. Atkins; Don V. Jackson; Frederick Richards II; Hyman B. Muss; H. Bradley Wells; Charles L. Spurr

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 350 KB
Volume: 65
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19900415)65:8<1700::aid-cncr2820650806>3.0.co;2-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of the combination of c

A phase II study of the combination of carboplatin and ifosfamide in previously untreated metastatic small cell lung carcinoma

✍ T. Le Chevalier; F. Thomas; R. Subirana; P. Baldeyrou; P. Ruffie; T. Tursz; R. A 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB 👁 2 views

A Phase II study of all-trans-retinoic a

A Phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma : An Eastern Cooperative Oncology Group study

✍ Gregory P. Kalemkerian; Michael Jiroutek; David S. Ettinger; John A. Dorighi; Da 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 1 views

The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.

Combination chemotherapy-radiotherapy wi

Combination chemotherapy-radiotherapy with and without the methanol-extraction residue of bacillus calmette-guerin (MER) in small cell carcinoma of the lung a prospective randomized trial of the piedmont oncology association

✍ Don V. Jackson Jr; Barton R. Paschal; Carolyn Ferree; Frederick Richards II; Hym 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB 👁 2 views

A randomized Phase II trial of echinomyc

A randomized Phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma : An Eastern Cooperative Oncology Group Study (E1587)

✍ Alex Y. Chang; KyungMann Kim; Hélène Boucher; Philip Bonomi; James A. Stewart; D 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## Background: Patients with metastatic nonsmall cell lung carcinoma (nsclc) usually have a poor prognosis. a chemotherapy regimen containing cisplatin is commonly used for symptom palliation. echinomycin is a potent bifunctional intercalator of double-strand dna; trimetrexate is a new derivative o

Gemcitabine, ifosfamide, cisplatin (GIP)

Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: A phase II study of the Italian oncology group for clinical research (goirc)

✍ C. Boni; G. Bisagni; L. Savoldi; G. Moretti; E. Rondini; M. Sassi; A. Zadro; T. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 55 KB 👁 2 views

Combination chemotherapy with and withou

Combination chemotherapy with and without the methanol-extracted residue of bacillus calmette-guerin (MER) in extensive non-small-cell lung cancer: A prospective randomized study for the piedmont oncology association

✍ Frederick Richards II; Virginia Howard; Anita Shore; Hyman B. Muss; Douglas R. W 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

One-hundred-three patients with extensive non-small-cell lung cancer were entered into a prospective, randomized trial to determine the value of MER as an adjuvant to chemotherapy. Patients were stratified according to histology and performance status. All patients received CCNU, methotrexate, and A